![Kamil Sebastian Sitarz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 186 046 $ in data 31/08/2026
Dr. Kamil Sebastian Sitarz is a Chief Operating Officer at Ryvu Therapeutics SA. He received his graduate degree from Uniwersytet Jagiellonski, an MBA from Cracow School of Business and a doctorate degree from Newcastle University Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RYVU THERAPEUTICS SA 0,17% | 30/09/2025 | 39.230 ( 0,17% ) | 186 046 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Direttore operativo | 23/11/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Uniwersytet Jagiellonski
 Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Cracow School of Business
 Cracow School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University Medical School
 Newcastle University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
